Bio-Techne
TECH
#1576
Rank
$10.73 B
Marketcap
$67.57
Share price
-6.85%
Change (1 day)
10.97%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2024 : $2.13 Billion USD

According to Bio-Techne's latest financial reports the company has $2.13 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$$1.96 B15.61%
2022-06-30$$1.70 B8.26%
2021-06-30$$1.57 B13.76%
2020-06-30$$1.38 B18.5%
2019-06-30$$1.16 B8.02%
2018-06-30$$1.07 B13.63%
2017-06-30$$0.94 B8%
2016-06-30$$0.87 B3.82%
2015-06-30$$0.84 B6.5%
2014-06-30$$0.79 B7.83%
2013-06-30$$0.73 B9.36%
2012-06-30$$0.67 B15.07%
2011-06-30$$0.58 B16.81%
2010-06-30$$0.50 B9.93%
2009-06-30$$0.45 B-6.29%
2008-06-30$$0.48 B11.31%
2007-06-30$$0.43 B28.59%
2006-06-30$$0.34 B27.06%
2005-06-30$$0.26 B-9.94%
2004-06-30$$0.29 B25.7%
2003-06-30$$0.23 B14.58%
2002-06-30$$0.20 B16.24%
2001-06-30$$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$49.09 B 2,195.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.48 B 250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.86 B 1,109.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$51.30 B 2,298.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.40 B 59.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$19.10 B 793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$56.11 M-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA